The Cell and Gene Therapy Catapult (CGT Catapult) and Deep Science Ventures have partnered to address barriers in the ATMP industry, create new companies and deliver better patient outcomes. Recent advances in cell and gene therapies promise potential cures to devastating diseases. However, major hurdles still need to be… Read More
Listen to this article on the DDW Podcast: Dr. Urmi Roy, Global Product Manager for Flow Cytometry Reagents, Miltenyi Biotec, explains why immunogenicity prediction is a key consideration for therapeutic development. Biologic drugs as therapy have improved the treatment of many diseases, but their success is often tempered by antidrug antibodies (ADAs),… Read More
Listen to this article on the DDW Podcast: Dr Andy Lane, Commercial Director at The Native Antigen Company, discusses the development of a new generation of vaccine platforms that can be rapidly adapted to novel threats on-demand and at low cost. Vaccines are one of the most effective healthcare interventions for reducing… Read More
BioIVT hosted a webinar in which researchers discussed how they used a sandwich-cultured human hepatocyte (SCHH) model to investigate the drug-drug interaction (DDI) potential of bempedoic acid, a drug that was recently approved to treat hypercholesterolemia. During Phase II and III trials of bempedoic acid, small, reversible increases in… Read More
Doreen Cantrell, Professor of Cellular Immunology at the University of Dundee’s School of Life Sciences, has been selected to join GSK’s Immunology Network. DDW’s Megan Thomas speaks to her about what this means for her career and the industry. MT: Congratulations on joining GSK’s Immunology Network. Can you elaborate on what… Read More
Thermo Fisher Scientific introduced new-generation mass spectrometry instruments, workflows and software during the 69th American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics, which was held October 31-November 4 in Pennsylvania. “The life science industry has stepped forward in an unprecedented fashion over the… Read More
Examining the role of the pharmaceutical industry in alleviating challenges is helpful to understand how people are benefiting from innovative medicines. This report examines the impact of the pharmaceutical industry in nine Latin American countries (Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, Mexico, Panama, and Peru) by analysing its impact across two dimensions of… Read More
Synlogic and Ginkgo Bioworks have nominated SYNB1353, an investigational synthetic biotic medicine for the treatment of homocystinuria (HCU). SYNB1353 is the first product developed through a research collaboration between Synlogic and Ginkgo and the first investigational medicine developed on Ginkgo’s platform to enter IND-enabling studies. Synlogic expects to file an investigational new drug (IND)… Read More
Medicine developer CatSci has collaborated with the Cambridge Crystallographic Data Centre (CCDC). CatSci’s experimental expertise in material science combined with CCDC’s informatics tools will offer an integrated solution to customers, adding strategic value from molecule to medicine. CCDC’s informatics-based services apply big data learnings from over one million published crystal structures to better… Read More
Listen to this article on the DDW Podcast: As part of the Fall Issue of DDW's Market Report, DDW Editor Lu Rahman explores the Chinese pharmaceutical landscape and what the new era of drug discovery is starting to look like in the country. China has a population of more than 1.4 billion people. Read More
Evonik met with a delegation of representatives from Canada at its site in Darmstadt to discuss competencies in lipid nanoparticles at Evonik’s Vancouver laboratories and evaluate future collaboration opportunities. Evonik has sites in seven locations in Canada including its Vancouver Laboratories in British Columbia for lipid-based parenteral drug delivery which… Read More
CN Bio has entered a research collaboration with the Infection Innovation Consortium (iiCON) to validate the next generation of Covid-19 research tools. iiCON’s £174 million programme brings together industry, academia, and clinicians to accelerate the discovery, development and deployment of new treatments and products. Led by the Liverpool School of… Read More
Australian clinical-stage drug development company Noxopharm has announced its DARRT-2 Phase II clinical trial has begun with patient enrollment in the US. It is said to have the potential to revolutionise cancer treatment by achieving cancer reduction without many of the unwanted side effects, cost limitations, and logistical challenges… Read More
While reported measles cases have fallen compared to previous years, progress toward measles elimination continues to decline and the risk of outbreaks is mounting, according to a new report from the World Health Organization (WHO) and US Centers for Disease Control and Prevention (CDC). During 2020, more than 22… Read More
Scientists in Singapore have assembled a large, high-resolution atlas of gastric cancer, a leading cause of global cancer death. The atlas provides, at the level of single cells, new insights into how gastric cancers progress and how tumours from separate patients differ from one another. The findings also identified molecular pathways… Read More
Jenny Bailey, CEO of Ferryx tells Lu Rahman how its leading product FX856 came to life and how it’s a game-changer for inflammatory bowel disease since it can act during active inflammation. Ferryx is an innovative bio-tech start-up. It is a University of Bristol spin-out with a focus on gut health and IBD in… Read More
